We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+33.14%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$376M
AUM Growth
+$60.4M
Cap. Flow
-$3.65M
Cap. Flow %
-0.97%
Top 10 Hldgs %
96.97%
Holding
22
New
7
Increased
3
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$4.24M
2
PLYA
Playa Hotels & Resorts
PLYA
+$3.16M
3
SBR
Sabine Royalty Trust
SBR
+$2.78M
4
UNIT
Uniti Group
UNIT
+$2.59M
5
BABA icon
Alibaba
BABA
+$2.48M

Top Sells

Rank Stock Value
1
MDXG icon
MiMedx Group
MDXG
+$14.4M
2
IBRX icon
ImmunityBio
IBRX
+$4.73M
3
CSGP icon
CoStar Group
CSGP
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 75.6%
2 Real Estate 14.49%
3 Miscellaneous 4.84%
4 Financials 2.34%
5 Consumer Discretionary 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$250M 66.42%
2,410,034
+51,950
+2% +$4.24M
CSGP icon
2
CoStar Group
CSGP
$12.8B
$47.9M 12.73%
1,816,720
-89,650
-5% -$2.18M
IBRX icon
3
ImmunityBio
IBRX
$8.63B
$25.7M 6.84%
3,391,539
-1,093,956
-24% -$4.73M
LPLA icon
4
LPL Financial
LPLA
$26.9B
$8.8M 2.34%
208,401
+1,754
+0.8% +$71.2K
EMB icon
5
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
$7.94M 2.11%
70,000
– –
UNIT
6
Uniti Group
UNIT
$2.37B
$6.61M 1.76%
263,000
+100,000
+61% +$2.59M
MDXG icon
7
CALL
MiMedx Group
MDXG
$689M
$5.85M 1.56%
+391,000
New +$5.22M
SRNE
8
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$5.6M 1.49%
2,799,790
– –
PLYA
9
DELISTED
Playa Hotels & Resorts
PLYA
$3.58M 0.95%
+300,000
New +$3.16M
SBR
10
Sabine Royalty Trust
SBR
$1.09B
$2.86M 0.76%
+74,505
New +$2.78M
BABA icon
11
Alibaba
BABA
$272B
$2.83M 0.75%
+20,068
New +$2.48M
FXY icon
12
Invesco CurrencyShares Japanese Yen Trust
FXY
$446M
$2.67M 0.71%
31,245
– –
URGN icon
13
UroGen Pharma
URGN
$2.04B
$2.44M 0.65%
+135,000
New +$2.34M
NH
14
DELISTED
NantHealth, Inc
NH
$1.01M 0.27%
15,922
– –
FXE icon
15
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$357M
$997K 0.27%
+9,023
New +$963K
UUP icon
16
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$322M
$728K 0.19%
+29,400
New +$747K
EDIT icon
17
Editas Medicine
EDIT
$404M
$693K 0.18%
41,324
– –
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
$38K 0.01%
1,500
– –
MDXG icon
19
MiMedx Group
MDXG
$689M
– –
-1,080,365
Closed -$14.4M
OEF icon
20
CALL
iShares S&P 100 ETF
OEF
$20.1B
– –
-9,560
Closed -$2.8M
TSLA icon
21
PUT
Tesla
TSLA
$1.41T
– –
-16,500
Closed -$306K
UUP icon
22
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$322M
– –
-985,100
Closed -$25.6M

Similar funds

IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
DCC
Dow Chemical Company Midland, Michigan $228M AUM 0.84% 1-Year Est. Return
TI
tru Independence Portland, Oregon $229M AUM 22.02% 1-Year Est. Return
SPFA
Summit Place Financial Advisors Summit, New Jersey $228M AUM 26.15% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
PPA
Painted Porch Advisors Santa Barbara, California $229M AUM 17.97% 1-Year Est. Return
SWIM
Smallwood Wealth Investment Management Red Bank, New Jersey $229M AUM 23.56% 1-Year Est. Return
PRRFG
Paul R. Ried Financial Group Bellevue, Washington $229M AUM 29.24% 1-Year Est. Return

Wildcat Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Wildcat Capital Management held 22 positions worth $376M, up 19% from $316M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Wildcat Capital Management's Q2 2017 filing shows 7 new, 3 increased, 2 reduced and 4 closed positions. Its largest new stake was Playa Hotels & Resorts: 300,000 shares worth $3.58M. The largest sale was MiMedx Group, an estimated $14.4M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 71% a quarter earlier, followed by Real Estate and Miscellaneous.

  • Wildcat Capital Management's largest Q2 2017 buy was Playa Hotels & Resorts: 300,000 shares worth $3.58M.
  • Wildcat Capital Management added most to Kite Pharma, Inc. in Q2 2017, an estimated $4.24M increase.
  • Wildcat Capital Management's biggest Q2 2017 reduction was ImmunityBio, cutting an estimated $4.73M.
  • Wildcat Capital Management fully exited MiMedx Group in Q2 2017, selling an estimated $14.4M.
  • Wildcat Capital Management's ten largest holdings make up 97% of its $376M portfolio in Q2 2017.
  • Wildcat Capital Management opened 7 new positions and closed 4 in Q2 2017.
  • Wildcat Capital Management's portfolio value rose 19% quarter-over-quarter to $376M.

Based on Wildcat Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.